The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study to Evaluate Effectiveness and Safety of Surgeries in Elderly NSCLC Patients
Official Title: A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness and Safety of Surgeries in the Chinese Early-stage Patients With Non-small Cell Lung Cancer
Study ID: NCT03429673
Brief Summary: The trial was designed to compare effectiveness and safety of surgeries in the patients with non-small cell lung cancer
Detailed Description: The trial is a multi-centre, real-world, non-interventional, observational study. The Chinese elderly pathologically diagnosed patients with early-stage non-small cell lung cancer enrolled from 2015 to 2017 who received lobectomy or segment/wedge dissection were included and the study data on patient demographic/tumor biological characteristics, and clinical treatments were retrospectively collected to evaluate effectiveness and safety of the surgeries.
Minimum Age: 65 Years
Eligible Ages: OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
China-Japan Friendship Hospital, Beijing, Beijing, China
China People's Liberation Army Hospital, Beijing, Beijing, China
Henan Cancer Hospital, Zhengzhou, Henan, China
Tongji Hospital Affiliated to Huaxi Technology University, Wuhan, Hubei, China
Jiangsu Cancer Hospital, Nanjing, Jiangsu, China
Xi'an Tangdu Hospital, Xi'an, Shaanxi, China
Shanghai Chest Hospital, Shanghai, Shanghai, China
Huaxi Hospital Affiliate to Sichuan University, Chengdu, Sichuan, China
Tianjin Chest Hospital, Tianjin, Tianjin, China
First Hospital Affiliated to Zhejiang University, Hangzhou, Zhejiang, China